Related Experiment Videos
Cystotomy for diabetic cystoid macular edema
N Tachi1, Y Hashimoto, N Ogino
1Shinseikai Toyama Hospital, Imizu, Japan. qzk10667@nifty.ne.jp
Documenta Ophthalmologica. Advances in Ophthalmology
|July 15, 2000
Summary
Vitrectomy with cystotomy shows promise for treating diabetic cystoid macular edema (CME). This surgical approach eliminated CME in most patients, with some experiencing improved visual acuity, suggesting its potential therapeutic role.
Area of Science:
- Ophthalmology
- Diabetic Retinopathy
- Macular Edema
Background:
- Diabetic cystoid macular edema (CME) is a significant cause of vision loss in diabetic patients.
- Current treatments for diabetic CME have limitations, necessitating novel therapeutic strategies.
Purpose of the Study:
- To investigate the efficacy and role of vitrectomy combined with cystotomy in managing diabetic CME.
- To assess the impact of this combined surgical approach on macular edema resolution and visual acuity.
Main Methods:
- A pilot study involving 22 eyes of 21 patients diagnosed with diabetic CME.
- All patients underwent phacoemulsification, intraocular lens implantation, pars plana vitrectomy, induction of posterior vitreous detachment, and either cystotomy or cystectomy.
- Follow-up ranged from 3 to 29 months with biomicroscopic examination.
Main Results:
- Cystoid macular edema (CME) was successfully eliminated in 16 out of 22 eyes.
- One eye exhibited residual ring-shaped edema.
- Corrected visual acuity improved by at least one Snellen line in 7 eyes ( P = 0.0391), remained stable in 13 eyes, and decreased in 2 eyes.
Conclusions:
- Vitrectomy with cystotomy appears to be a viable surgical option for treating diabetic cystoid macular edema (CME).
- The procedure demonstrated significant resolution of macular edema and potential for visual acuity improvement in a subset of patients.
- Further research is warranted to confirm these findings and establish the long-term efficacy of this treatment modality.